Valuation: HeartBeam, Inc.

Market Cap 41.63M 36.55M 33.64M 31.35M 59.12M 3.96B 60.33M 405M 157M 1.94B 156M 153M 6.76B P/E 2026 *
-1.99x
P/E 2027 * -2.47x
Enterprise Value 41.63M 36.55M 33.64M 31.35M 59.12M 3.96B 60.33M 405M 157M 1.94B 156M 153M 6.76B EV / Sales 2026 *
57.6x
EV / Sales 2027 * 8.35x
Free-Float
86.1%
Yield 2026 *
-
Yield 2027 * -
1 day-0.27%
1 week+7.76%
Current month-0.40%
1 month-15.49%
3 months-38.77%
6 months-69.26%
Current year-68.88%
1 week 0.61
Extreme 0.6106
0.77
1 month 0.61
Extreme 0.6106
0.94
Current year 0.61
Extreme 0.6106
2.88
1 year 0.54
Extreme 0.54
4
3 years 0.54
Extreme 0.54
4
5 years 0.54
Extreme 0.54
6.74
10 years 0.54
Extreme 0.54
6.74
Manager TitleAgeSince
Chief Executive Officer 59 2024-10-20
Chief Executive Officer 71 2014-12-31
Director of Finance/CFO 45 2024-09-08
Director TitleAgeSince
Director/Board Member 71 2014-12-31
Chairman 73 2015-06-10
Chairman 72 2021-05-31
Date Insider Type Main position Quantity % Market Cap.
04-15Buy

Director

750,000 1.8254%
04-15Buy

Chief Executive Officer

12,500 0.0304%
04-15Buy

Founder

31,250 0.0761%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+7.76%-39.02%-69.76% 41.63M
-0.09%+4.56%+4.80%-27.84% 16.47B
+12.91%+7.10%+35.37%+90.87% 1.51B
+6.14%+51.88%-37.75%-77.72% 1.19B
+1.90%-0.06%-29.59%+31.57% 1.09B
+4.06%-9.04%-24.97%-53.14% 612M
+1.90%-2.35%-38.86%-55.88% 583M
+1.68%+1.64%+22.99%-55.79% 440M
+0.49%-3.16%-56.37%-60.98% 371M
+1.84%-1.34%+36.57%+26.97% 329M
Average +2.99%+7.07%-12.68%-25.17% 2.26B
Weighted average by Cap. +1.21%+8.94%+0.74%-21.46%

Financials

2026 *2027 *
Net sales 723K 635K 585K 545K 1.03M 68.77M 1.05M 7.03M 2.72M 33.76M 2.72M 2.66M 117M 4.98M 4.38M 4.03M 3.75M 7.08M 474M 7.22M 48.44M 18.77M 233M 18.71M 18.31M 809M
Net income -19.4M -17.03M -15.68M -14.61M -27.55M -1.84B -28.11M -189M -73.05M -905M -72.83M -71.26M -3.15B -18.67M -16.39M -15.09M -14.06M -26.52M -1.78B -27.06M -182M -70.32M -871M -70.11M -68.59M -3.03B
Net Debt - -
Logo HeartBeam, Inc.
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Employees
17
Date Price Change Volume
26-07-01 US$0.7402 -1.31% 304,498
26-06-30 US$0.7500 +14.80% 879,208
26-06-29 US$0.6533 -3.27% 335,728
26-06-26 US$0.6754 +5.53% 685,192
26-06-25 US$0.6400 -7.67% 919,672
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.7500USD
Average target price
3.833USD
Spread / Average Target
+411.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BEAT Stock